![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
DDW/2016: Barriers to [Veterans] Hepatitis C Treatment in the DAA era
|
|
|
Reported by Jules Levin
DDW May 21-24 2016 San Diego, CA
Michael Lin1, Jennifer Kramer2,3, Donna White2,3, Shahriar Tavakoli-Tabasi4, Hashem El-Serag1,2,3, Fasiha Kanwal1,2,3
1Department of Gastroenterology and Hepatology, Baylor College of Medicine, Houston, TX, USA
2Center of InnovaPon, EffecPveness and Quality, Michael E. DeBakey Veterans Affairs Medical Center, Houston , TX, USA
3SecPon of Health Services Research, Michael E. DeBakey Veterans Affairs Medical Center, Houston , TX, USA
4Department of InfecPous Diseases, Michael E. DeBakey Veterans Affairs Medical Center, Houston , TX, USA
![EASL1](../images/052616/052616-2/EASL1.gif)
![EASL2](../images/052616/052616-2/EASL2.gif)
![EASL3](../images/052616/052616-2/EASL3.gif)
![EASL4](../images/052616/052616-2/EASL4.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|